NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 871 filers reported holding NOVARTIS A G in Q3 2014. The put-call ratio across all filers is 0.59 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $6,534,000 | -8.1% | 82,753 | -4.0% | 2.32% | -7.0% |
| Q2 2016 | $7,113,000 | +12.5% | 86,213 | -1.2% | 2.49% | +9.5% |
| Q1 2016 | $6,320,000 | -16.2% | 87,243 | -0.5% | 2.28% | -13.3% |
| Q4 2015 | $7,541,000 | -15.1% | 87,642 | -3.0% | 2.62% | -12.2% |
| Q2 2015 | $8,884,000 | -1.8% | 90,337 | -1.6% | 2.99% | -3.0% |
| Q1 2015 | $9,049,000 | +6.0% | 91,767 | -0.4% | 3.08% | +3.8% |
| Q4 2014 | $8,536,000 | -1.4% | 92,117 | +0.2% | 2.97% | -5.2% |
| Q3 2014 | $8,657,000 | +4.6% | 91,967 | +0.6% | 3.13% | +11.2% |
| Q2 2014 | $8,277,000 | +5.6% | 91,426 | -0.8% | 2.82% | +2.0% |
| Q1 2014 | $7,836,000 | +7.8% | 92,166 | +1.9% | 2.76% | +6.1% |
| Q4 2013 | $7,272,000 | +4.1% | 90,466 | -0.6% | 2.60% | -3.8% |
| Q3 2013 | $6,983,000 | +8.4% | 91,036 | -0.0% | 2.71% | +1.0% |
| Q2 2013 | $6,439,000 | – | 91,066 | – | 2.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GODSEY & GIBB, INC | 184,900 | $15,121,000 | 6.74% |
| Martin Investment Management, LLC | 289,924 | $23,710,000 | 5.98% |
| Camber Capital Management LP | 2,000,000 | $163,560,000 | 5.04% |
| MANAGED ASSET PORTFOLIOS, LLC | 381,778 | $31,222,000 | 4.76% |
| PROFESSIONAL ADVISORY SERVICES INC | 267,779 | $21,899,000 | 3.22% |
| SCHARF INVESTMENTS, LLC | 1,244,711 | $101,794,000 | 3.21% |
| GARLAND CAPITAL MANAGEMENT INC | 50,755 | $4,151,000 | 2.97% |
| First Fiduciary Investment Counsel, Inc. | 167,378 | $13,688,000 | 2.67% |
| WILKINS INVESTMENT COUNSEL INC | 130,590 | $10,680,000 | 2.61% |
| Lowell Blake & Associates Inc. | 66,309 | $5,423,000 | 2.52% |